Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-21-016280
Filing Date
2021-10-22
Accepted
2021-10-22 16:07:18
Documents
1
Period of Report
2021-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp160198_4-pulik.html 4  
1 FORM 4 dp160198_4-pulik.xml 4 4229
  Complete submission text file 0000950103-21-016280.txt   5606
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES'S SQUARE LONDON X0 SW1Y 4LB
Business Address
Pulik Richard (Reporting) CIK: 0001885841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 211340629